Exchange: NASDAQ·Updated 01:54 PM EDT
REGN logo

REGNRegeneron Pharmaceuticals, Inc.

$642.86
$18.14
(2.90%)
Today
EarningsJul 30
Mkt Cap$65.5B
Vol404,858.00
Upcoming Earnings: Q2 '26

Reports: Jul 30Pre-Market

Estimated EPS

$10.81

Estimated Rev

$3.81B

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
$10.81
--
--
N/A
Q1 '26
$8.91
$9.47
6.24%
BEAT
Q4 '25
$10.74
$11.44
6.56%
BEAT
Q3 '25
$9.65
$11.83
22.53%
BEAT
Q2 '25
$8.43
$12.89
52.89%
BEAT

Advertisement|Remove ads.